Teclison (Equity)
Funding Details
- Awarder
- Inbox
- Date Award
- February 14, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $5,900,000
Company Info
- Founders
- Ray Lee
- Company Description
- Teclison is to develop new drugs to treat cancer and other diseases with strong unmet medical needs.
- Market
- Cancer therapeutics
- Location
- Montclair, NJ, USA
- Coinvestors
- Nestor Capital, W.T.T. Investment